Abstract
Growing clinical evidence suggests that metabolic behavior and atherogenic potential vary within lipoprotein subclasses that can be defined by apolipoprotein variation. Variant constituency of apolipoproteins B and E (apoB and apoE) may be particularly important because of the central roles of these apolipoproteins in the endogeneous lipid delivery cascade. ApoB is the sole protein of low-density lipoprotein (LDL), and like LDL cholesterol, the plasma apoB level has been positively correlated with risk for atherosclerotic disease. ApoE is a major functional lipoprotein in the triglyceride-rich lipoproteins, and may be crucial in the conversion of very low density lipoprotein (VLDL) to LDL. Based on work by others that enabled the quantititation of apoB-containing particles by content of up to two other types of apolipoprotein, we have developed a method for determining the amount of apoE in apoB-containing lipoproteins (Lp B:E) and the amount of apoB in apoE-containing lipoproteins (Lp E:B). From the Lp B:E and Lp E:B concentrations, the molar ratio of apoE to apoB in lipoproteins containing apoB and/or apoE in plasma can be determined. The methodology is fast, specific, and sensitive and should prove extremely useful in further categorizing lipoproteins and characterizing their behavior. In applying this method to clinical groupings of normo- and hyperlipidemia, we found that the plasma triglyceride level correlated with the apoE and Lp B:E concentrations in plasma, while the total cholesterol level correlated with the apoB and Lp E:B levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agnani, G., Bard, J. M., Chandelier, L., Delattre, S., Fruchart, J. C., and Clavey, V. (1991). Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.Arterioscler. Thromb.11, 1021–1029.
Alaupovic, P. (1980). The concepts, classification systems and nomenclatures of human plasma lipoproteins. InCRC Handbook of Electrophoresis. Lipoproteins: Basic Principles and Concepts (Lewis, L. A., and Opplt, J. J., eds.), CRC Press, Boca Raton, Florida, pp. 27–46.
Albers, J. J., Brunzell, J. D., and Knapp, R. H. (1989). Apoprotein measurements and their clinical application,Cholesterol Screening 9, 137–152.
Castro, G. R., and Fielding, C. J. (1988). Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein,Biochemistry 27, 25–29.
Fievet, C., Koffigan, M., Ouvry, D., Marcovina, S., Moschetto, Y., and Fruchart, J. C. (1984). Noncompetitive enzymelinked immunoassay for apolipoprotein B in serum,Clin. Chem. 30, 98–100.
Harlow, E., and Lane, D., eds. (1988). Storage and purifying of antibodies, inAntibodies. A Laboratory Manual, Cold Spring Harbor Laboratory, pp. 287–318.
Hurn, B. A., and Chantler, S. M. (1980). Production of reagent of antibodies,Meth. Enzymol. 70, 104–142.
Kandoussi, A., Cachera, C., Parsy, D., Bard, J. M., and Fruchart, J. C. (1991). Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: ApoB with apo C-III and apo B with apoE,J. Immunoassay 12, 305–323.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent,J. Biol. Chem. 193, 265–275.
Luc, G., Parra, H. J., Zylberberg, G., and Fruchart, J. C. (1991). Plasma concentrations of apolipoprotein A-I containing particles in normolipidemic young men,Eur. J. Clin. Invest. 21, 118–122.
Mahley, R. W. (1988). Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology,Science 240, 622–630.
Reisen, W. F., Sturzenegger, E., Imhof, C., and Mordasini, R. (1986). Quantitation of apolipoprotein B by polyclonal and monoclonal antibodies,Clin. Chim. Acta 154, 29–40.
Sandkamp, M., Tambyrajah, B. M., Assmann, G., and Schriewer, H. (1992). Determination of apolipoprotein B in apolipoprotein CII/CIII-containing lipoproteins by an immunoenzymetric assay,Eur. J. Clin. Chem. Clin. Biochem. 30, 223–228.
Steinbuch, M. D., and Audran, R. (1969). The isolation of IgG from mammalian sera with the aid of caprylic acid,Arch. Biochem. andBiophys. 134, 279–284.
Stevenson, S. C., Sawyer, J. K., and Rudel, L. L. (1992). Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates,Arterioscler. Thromb. 12, 28–40.
Suernam, A., McConathy, W. J., Alaupovic, P. (1979). Evidence for the lipoprotein heterogeneity of human plasma high density lipoprotein isolated by three different procedures,Lipids 14, 505–510.
Tyroler, H. A. (1987). Review of lipid-lowering clinical trials in relation to observational epidemiologic studies,Circulation 766, 515–522.
Weisgraber, K. H., Rall, S. C., and Mahley, R. W. (1981). Human E apoprotein heterogeneity: Cysteine-argine interchanges in the amino acid sequence of the apoE isoforms,J. Biol. Chem. 256, 9077–9083.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, CY., Xie, YH., Yang, M. et al. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in apoB-containing lipoproteins (Lp B:E) and apoB in apoE-containing lipoproteins (Lp E:B). J Protein Chem 14, 503–509 (1995). https://doi.org/10.1007/BF01886876
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01886876